132 related articles for article (PubMed ID: 9025109)
1. The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine.
Murray TK; Williams JL; Misra A; Colado MI; Green AR
Neuropharmacology; 1996; 35(11):1615-20. PubMed ID: 9025109
[TBL] [Abstract][Full Text] [Related]
2. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
Colado MI; O'Shea E; Granados R; Murray TK; Green AR
Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
[TBL] [Abstract][Full Text] [Related]
3. The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.
Colado MI; Green AR
Eur J Pharmacol; 1995 Jul; 280(3):343-6. PubMed ID: 8566105
[TBL] [Abstract][Full Text] [Related]
4. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
Colado MI; Murray TK; Green AR
Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
[TBL] [Abstract][Full Text] [Related]
5. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY
Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
[TBL] [Abstract][Full Text] [Related]
6. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.
Colado MI; Granados R; O'Shea E; Esteban B; Green AR
Br J Pharmacol; 1998 Jun; 124(3):479-84. PubMed ID: 9647471
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
Fattaccini CM; Gozlan H; Hamon M
Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
[TBL] [Abstract][Full Text] [Related]
8. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
Dewar KM; Grondin L; Carli M; Lima L; Reader TA
J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
[TBL] [Abstract][Full Text] [Related]
9. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy.
Bergqvist PB; Hjorth S; Wikell C; Apelqvist G; Bengtsson F
Metab Brain Dis; 1997 Sep; 12(3):229-36. PubMed ID: 9346471
[TBL] [Abstract][Full Text] [Related]
10. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats.
Hewitt KE; Green AR
Neuropharmacology; 1994 Dec; 33(12):1589-95. PubMed ID: 7539115
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').
O'Shea E; Granados R; Esteban B; Colado MI; Green AR
Neuropharmacology; 1998 Jul; 37(7):919-26. PubMed ID: 9776387
[TBL] [Abstract][Full Text] [Related]
12. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles.
Malberg JE; Seiden LS
Brain Res; 1997 Aug; 765(1):101-7. PubMed ID: 9310399
[TBL] [Abstract][Full Text] [Related]
13. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo.
Series HG; Cowen PJ; Sharp T
Psychopharmacology (Berl); 1994 Dec; 116(4):508-14. PubMed ID: 7535469
[TBL] [Abstract][Full Text] [Related]
14. Central serotonin depletion affects rat brain areas differently: a qualitative and quantitative comparison between different treatment schemes.
Kornum BR; Licht CL; Weikop P; Knudsen GM; Aznar S
Neurosci Lett; 2006 Jan; 392(1-2):129-34. PubMed ID: 16213658
[TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of p-chloroamphetamine neurotoxicity.
Sprague JE; Johnson MP; Schmidt CJ; Nichols DE
Biochem Pharmacol; 1996 Oct; 52(8):1271-7. PubMed ID: 8937435
[TBL] [Abstract][Full Text] [Related]
16. Endogenously produced 5,6-dihydroxytryptamine may mediate the neurotoxic effects of para-chloroamphetamine.
Commins DL; Axt KJ; Vosmer G; Seiden LS
Brain Res; 1987 Sep; 419(1-2):253-61. PubMed ID: 2445423
[TBL] [Abstract][Full Text] [Related]
17. Effect of p-chlorophenylalanine at moderate dosage on 5-HT and 5-HIAA concentrations in brain regions of control and p-chloroamphetamine treated rats.
Datla KP; Curzon G
Neuropharmacology; 1996 Mar; 35(3):315-20. PubMed ID: 8783206
[TBL] [Abstract][Full Text] [Related]
18. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
Sanchez V; Camarero J; Esteban B; Peter MJ; Green AR; Colado MI
Br J Pharmacol; 2001 Sep; 134(1):46-57. PubMed ID: 11522596
[TBL] [Abstract][Full Text] [Related]
19. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
20. The effect of D-fenfluramine on brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male and female rats.
Datla KP; Curzon G
Eur J Pharmacol; 1997 Aug; 333(1):27-31. PubMed ID: 9311657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
